GLP1 receptor agonists are looking like longevity drugs. A new study reports that drug-induced improvements in bone mass are mediated by the NAD-dependent SIRT1 enzyme. If so, could NAD boosters work with GLP-1 drugs? Some thoughts...🧵
2
This new study is consistent with studies showing NMN, an NAD booster & SIRT1 activator, improves bone mass in mice
3
This paper summarizes the evidence that GLP1RA drugs benefits bone
4
NMN has been shown in mice to improve healing of broken bones..
5
And this one on SIRT1's benefits on bone:
6
But be aware that these drugs can have negative side effects on the kidney, muscle and even increase the chances of sudden blindness! jamanetwork.com/journals/jamao…
Another side effect of GLP-1RA is muscle loss. Perhaps NAD boosters could help with this side effect, especially given there is evidence from a small study @BrighamWomens that people have more leg endurance after 4 weeks on NMN